Is Boston Scientific Stock a Buy?
Boston Scientific (NYSE: BSX) shares are off to a sluggish start this year, down 4.8% so far after climbing 28% in 2019. And the medical device maker's outlook for the current quarter may mean investors will have to wait a while for additional gains.
What's weighing on the company's outlook? The same problem that has made global headlines these past several weeks: the coronavirus.
Image source: Getty Images
Source Fool.com


